Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5830729

Title:I Sce I-induced gene replacement and gene conversion in embryonic stem cells
Inventors:Jaisser, Frederic; Malakoff, France
Cohen-Tannoudji, Michel; Paris, France
Robine, Sylvie; Vanves, France
Choulika, Andre; Paris, France
Louvard, Daniel; Sceaux, France
Babinet, Charles; Paris, France
Summary:Described herein is a method of homologous recombination for a locus in a villin gene via the introduction of an I-SceI restriction site. The invention relates to a method of constructing a villin gene hybrid by inserting an I-Sce I restriction site next to or within a gene or cDNA encoding a villin protein, such that the location of insertion of the I-Sce I restriction site is chosen to provide a first downstream part and a second upstream part from the site, which contains at least twelve nucleotides of the gene or cDNA encoding the villin protein. Claims of the invention include a high frequency of homologous recombination events that result from the insertion of the restriction site. Therapeutic applications of the villin gene hybrid include its use in the transfection of eukaryotic cells such as embryonic stem cells.
Abstract:This invention relates to a method of constructing a villin gene hybrid by inserting an I-Sce I restriction site next to or within a gene or cDNA encoding a villin protein. The insertion site of the I-Sce I restriction site is chosen as to provide a first downstream part and a second upstream part from the site, containing at least twelve nucleotides of the gene or cDNA encoding the villin protein. Furthermore, the insertion of the restriction permits a high frequency of homologous recombination events. The villin gene hybrid may be used to transfect eukaryotic cells, and particularly, embryonic stem cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5830729
Application Number:US1996000693948
Date Filed:07/08/1996
Date Published:03/11/1998
Assignee:Institut Pasteur, Paris, France Institut Curie, Paris, France Centre National de la Recherche Scientifique, Paris, France


 
Copyright © 2007 The Institute for Cellular Medicine  6/13/2021